Equitec Proprietary Markets’s Applied Therapeutics APLT Stock Holding History

Equitec Proprietary Markets’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300,600	Closed	-$30.1K	–	83
2025 Q4	$30.1K	Buy	+300,600	New	+$191K	0.02%	50

Equitec Proprietary Markets's APLT Position: Q1 2026 in Review

Equitec Proprietary Markets sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 300,600 shares — an estimated $30.1K sold.

Equitec Proprietary Markets first reported a position in APLT in Q4 2025 and held it in 1 quarter. The position peaked at $30.1K in Q4 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Equitec Proprietary Markets reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Equitec Proprietary Markets sold 300,600 Applied Therapeutics shares in Q1 2026, an estimated $30.1K.
Equitec Proprietary Markets first reported a position in Applied Therapeutics in Q4 2025 and held it in 1 quarter.
Equitec Proprietary Markets's Applied Therapeutics position peaked at $30.1K in Q4 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Equitec Proprietary Markets's 13F filing for Q1 2026, filed 11 May 2026.